Westrock Coffee Co
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
WEST$8.88+1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Unaudited)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Nine Months Ended September 30, | ||||||
| (Thousands) | 2025 | 2024 | ||||
| Cash flows from operating activities: | | | | | | |
| Net loss | | $(67,884) | | $(55,691) | ||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | | | | | | |
| Depreciation and amortization | | | 40,669 | | | 23,196 |
| Impairment charges | | | — | | | 1,996 |
| Equity-based compensation | | | 11,709 | | | 8,508 |
| Provision for credit losses | | | 165 | | | 1,368 |
| Amortization of deferred financing fees included in interest expense | | | 2,744 | | | 2,432 |
| Write-off of unamortized deferred financing fees | | | 137 | | | — |
| Loss on disposal of property, plant and equipment | | | 15 | | | 965 |
| Gain on de-consolidation of Rwanda Trading Company | | | (2,291) | | | — |
| Mark-to-market adjustments | | | (983) | | | (2,692) |
| Change in fair value of warrant liabilities | | | — | | | (7,134) |
| Foreign currency transactions | | | (141) | | | 461 |
| Deferred income tax expense (benefit) | | | 1,336 | | | 1,133 |
| Other | | | (4,784) | | | 1,003 |
| Change in operating assets and liabilities: | | | | | | |
| Accounts receivable | | | (3,932) | | | (4,930) |
| Inventories | | | (54,752) | | | (7,191) |
| Derivative assets and liabilities | | | (12,025) | | | 12,685 |
| Prepaid expense and other assets | | | (1,891) | | | 1,447 |
| Accounts payable | | | 18,795 | | | (2,650) |
| Accrued liabilities and other | | | 17,410 | | | 9,071 |
| Net cash used in operating activities | | | (55,703) | | | (16,023) |
| Cash flows from investing activities: | | | | | | |
| Additions to property, plant and equipment | | | (79,885) | | | (141,451) |
| Additions to intangible assets | | | (85) | | | (144) |
| Proceeds from sale of equity method investments and non-marketable securities | | | 500 | | | — |
| Acquisition of equity method investments and non-marketable securities, inclusive of cash contributed | | | (2,952) | | | — |
| Proceeds from sale of property, plant and equipment | | | 329 | | | 1,225 |
| Proceeds from deferred purchase price of sold trade receivables | | | 3,924 | | | — |
| Net cash used in investing activities | | | (78,169) | | | (140,370) |
| Cash flows from financing activities: | | | | | | |
| Payments on debt | | | (61,215) | | | (151,968) |
| Proceeds from debt | | | 161,923 | | | 250,882 |
| Payments on supply chain financing program | | | (131,068) | | | (121,203) |
| Proceeds from supply chain financing program | | | 150,937 | | | 114,008 |
| Proceeds from convertible notes payable | | | — | | | 22,000 |
| Proceeds from convertible notes payable - related party | | | — | | | 50,000 |
| Payment of debt issuance costs | | | (2,730) | | | (3,329) |
| Payment of convertible notes payable issuance costs | | | — | | | (511) |
| Net proceeds from (repayments of) repurchase agreements | | | 11,161 | | | (7,111) |
| Net change in unremitted cash collections from servicing factored receivables | | | 7,896 | | | — |
| Proceeds from exercise of stock options | | | — | | | 12 |
| Proceeds from issuance of common stock | | | 12,097 | | | 635 |
| Payment of equity issuance costs | | | (181) | | | (10) |
| Payment for taxes for net share settlement of equity awards | | | (2,079) | | | (2,041) |
| Net cash provided by financing activities | | | 146,741 | | | 151,364 |
| Effect of exchange rate changes on cash | | | (49) | | | (131) |
| Net increase (decrease) in cash and cash equivalents and restricted cash | | | 12,820 | | | (5,160) |
| Cash and cash equivalents and restricted cash at beginning of period | | | 35,564 | | | 37,840 |
| Cash and cash equivalents and restricted cash at end of period | | $48,384 | | $32,680 | ||
| | | | | | | |
| Supplemental non-cash investing and financing activities: | | | | | | |
| Property, plant and equipment acquired but not yet paid | | $8,648 | | $8,275 | ||
| Amounts obtained as beneficial interest in sold trade receivables | | | 5,766 | | | — |
The total cash and cash equivalents and restricted cash at September 30, 2025 and 2024 is as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| (Thousands) · September 30, 2025 · September 30, 2024 | ||||||
| Cash and cash equivalents | | $33,971 | | $22,359 | ||
| Restricted cash | | | 14,413 | | | 10,321 |
| Total | | $48,384 | | $32,680 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.